Marvell Technology (MRVL) had the highest return in Q2 2000 by a large-cap US stock, returning 280%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Marvell Technology (MRVL) | Q2 2000 | 280% |
Vertex Pharmaceuticals (VRTX) | Q2 2000 | 119.82% |
CoreSite Realty (COR) | Q2 2000 | 107.54% |
Trimble (TRMB) | Q2 2000 | 87.74% |
Quest Diagnostics (DGX) | Q2 2000 | 86.88% |
Bio-Techne (TECH) | Q2 2000 | 85.88% |
Exelixis (EXEL) | Q2 2000 | 85.42% |
Laboratory Corporation of America (LH) | Q2 2000 | 84.18% |
Waste Connections (WCN) | Q2 2000 | 64.57% |
Cardinal Health (CAH) | Q2 2000 | 60.07% |
Sun Life Financial (SLF) | Q2 2000 | 56.98% |
Eli Lilly and (LLY) | Q2 2000 | 55.97% |
Lennox International (LII) | Q2 2000 | 52.7% |
EOG Resources (EOG) | Q2 2000 | 52.47% |
Neurocrine Biosciences (NBIX) | Q2 2000 | 52.14% |
NVIDIA (NVDA) | Q2 2000 | 51.94% |
Teva Pharma Industries Ltd ADR (TEVA) | Q2 2000 | 47.51% |
MetLife (MET) | Q2 2000 | 45.26% |
Johnson & Johnson (JNJ) | Q2 2000 | 44.77% |
Republic Services (RSG) | Q2 2000 | 44.63% |
Rambus (RMBS) | Q2 2000 | 44.56% |
UnitedHealth (UNH) | Q2 2000 | 44.42% |
Tower Semiconductor (TSEM) | Q2 2000 | 43.41% |
BlackRock (BLK) | Q2 2000 | 43.21% |
United Therapeutics (UTHR) | Q2 2000 | 41.15% |
Large-cap stocks are treated as having a market cap of $10B+.
